UMEM Educational Pearls

Title: Is the anion gap metabolic acidosis due to alcoholic ketoacidosis or toxic alcohol ingestion?

Category: Toxicology

Keywords: alcoholic ketoacidosis, toxic alcohol ingestion, anion gap metabolic acidosis (PubMed Search)

Posted: 1/21/2021 by Hong Kim, MD
Click here to contact Hong Kim, MD

 

Anion gap metabolic acidosis is often found in ED patients. It can be difficult to distinguish between toxic alcohol (TA) ingestion and alcoholic ketoacidosis (AKA).  A retrospective study attempted to identify risk factors associated with AKA when TA ingestion was the alternative diagnosis.

 

New York City poison center data was reviewed from Jan 1, 2000 to April 30, 2019.

Case definition of AKA included

  1. Documented alcohol use disorder
  2. Urine or serum ketones or elevated blood beta-hydroxybutyrate concentration
  3. Anion gap >=14 mmol/L

Case definition of TA ingestion

  1. Detectable methanol or ethylene glycol concentration

Results

  • 699 patients were screened.
  • AKA diagnosis: 86
  • TA ingestion: 36

Univariate analysis showed following variables to be associated with AKA diagnosis

  • Ethanol level: OR 1.007 (95% CI: 1.001 – 1.013)
  • Anion gap: OR 1.063 (95% CI: 1.007-1.122)
  • Age (years): OR 1.036 (95% CI: 1.005 – 1.068)

Multivariate logistic regression showed elevated ethanol concentration was associated with increased odd of AKA diagnosis 

Conclusion

  • In this retrospective study, the odd of AKA diagnosis increased as ethanol concentration increased.
  • TA ingestion remains challenging diagonsis without the availability of obtaining real time TA concentration.


Title: Mammalian meat allergy (alpha-gal syndrome) following tick bites

Author: Dan Gingold, MD, MPH

Development of IgE antibodies to the oligosaccharide galactose-alpha-1-3-galactose (alpha-gal) appears to be responsible for an acquired allergy to non-primate mammalian meat (i.e., beef and pork) and derived productsAntigen in the salivary apparatus of certain ticks (gross!!) can sensitize an IgE-mediated response to alpha-gal which is present in mammalian meat. 

 
Symptoms are similar to other IgE-mediated hypersensitivity reactions, and can cause a delayed-onset reaction with hives, GI upset, or anaphylaxis after ingestion of red meat. Treatment with standard anti-histamines and epinephrine is effectiveIndividuals with no prior history of meat sensitivity can develop the syndrome at any age, often after exposure to the outdoors in tick-endemic areasSkin and blood allergy testing can confirm the diagnosis. Symptoms can persist for years, but can recede over time if not exposed to further tick bites.

 
In the US, the primary tick responsible is Lone Star Tick (Amblyomma americanum), found primarily in the Eastern, Southeastern, and Midwestern US. Other tick species in Europe, Australia, and Asia have been found to induce the syndrome as well. Interestingly, there is a cross-reactivity with the monoclonal antibody Cetuximab (used to treat colorectal and head and neck cancers), an allergic reaction to which can also induce similar alpha-gal meat sensitivity.

Having first been described in 2009, the syndrome often goes unrecognized; increased physician awareness can inform the evaluation, diagnosis, and education of patients presenting to the ED with undifferentiated allergic reaction.

 
 

 

Show References



 

Show References



Title: Lactate use in pediatric sepsis

Category: Pediatrics

Keywords: Infection, sepsis, lactic acid (PubMed Search)

Posted: 1/15/2021 by Jenny Guyther, MD (Updated: 11/25/2024)
Click here to contact Jenny Guyther, MD

Despite a lack of formal guidelines and evidence, lactate measurement has become a component of many pediatric emergency sepsis quality programs, with one survey showing that up to 68% of responding pediatric emergency medicine providers routinely measured it.

The Surviving Sepsis Campaign, last updated in February 2020, could not make a recommendation on the use of lactate in pediatric patients with suspected shock. The authors did state that lactate levels are often measured during the evaluation of septic shock if the lab can be obtained rapidly. However, lactate levels alone would not be an appropriate screening test.

Show References



Title: Do All Post-tPA Patients Require ICU Care?

Category: Neurology

Keywords: stroke, thrombolysis, tissue plasminogen activator, tPA, monitoring (PubMed Search)

Posted: 1/13/2021 by WanTsu Wendy Chang, MD
Click here to contact WanTsu Wendy Chang, MD

  • Acute ischemic stroke patients are commonly admitted to an ICU after receiving IV tPA to be closely monitored for potential complications.
  • Current post-tPA protocol requires frequent vital signs and neurological assessments up to every 15 minutes, thereby requiring 1:1 or 1:2 nurse-to-patient ratio.
  • Studies have shown that stroke severity is a strong predictor of the need for critical care interventions for post-tPA patients, where patients with an NIHSS score ≥10 have an ~8x higher odds of requiring critical care interventions than those with NIHSS <10.
  • A low-intensity post-tPA monitoring protocol (Figure 1) for patients with NIHSS <10 and no critical care needs has been found to be safe in a small single center study.
    • These low risk patients were admitted with telemetry monitoring and 1:3 nurse-to-patient ratio after an initial period of q15 min standard monitoring.
    • An international, multicenter, randomized controlled trial is being planned to study this further.

  • This strategy may help streamline care and utilize hospital resources more efficiently in the COVID-19 pandemic and beyond.

Bottom Line: Patients with NIHSS <10 may be safe for low-intensity post-tPA monitoring if they do not require critical care after an initial period of q15 min standard monitoring for the first 2 hours.

Show References



A single center (Nebraska, USA), retrospective analysis investigated the prevalence of intubation during hospital stay for 105 patients who had COVID-19 between March 24 to May 5, 2020 (1).   40 patients underwent awake proning vs. 60 patients did not undergo awake proning.

After adjusting for either SOFA or APACHE scores, patients with awake proning were associated with lower Hazard Ratios of intubation for SOFA (HR 0.30, 95% CI 0.09-0.96, p=0.043) and APACHE (HR 0.30, 95%CI 0.1-0.91, p=0.034).

 

 

Discussion

While this US study seemed promising, another Brazilian study being published earlier in July 2020 showed no difference in the prevalence of intubation between COVID-19 patients with proning or without proning (2).

These 2 studies highlighted the nature of this disease: high practice variability, uncertainty of therapeutic modalities.  However, the complications from awake proning had been very low.

Conclusion:

Awake proning for hypoxic COVID-19 patients is a promising intervention but we will need more studies.  In the meanwhile, we can try this therapeutic modality as the risk is low.

Show References



A recent retrospective observational study looked at the association of oral antibiotics (primarily fluroquinolones) and tendon rupture.

Outcome data is very interesting for our practice, deviates from traditional teaching.

Population:  1 million Medicare fee for service beneficiaries from 2007-2016 (>65 years old)

Antibiotics queried:  Seven total oral antibiotics of mixed class:

  1. Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin)
  2. Other:  Amoxicillin, amoxicillin-clavulanate, azithromycin and cephalexin.

 

Outcome measures:  all combined tendon ruptures and 3 by anatomic site (Achilles, rotator cuff {RC} and other)

Results:  Of the 3 quinolones, only LEVOfloxacin showed a significant increase in risk of tendon rupture (16% for RC) and (120% for Achilles) in a 1 month window. The others did not show an increased risk

Among the other antibiotics, cephalexin showed an increase risk across all anatomic sites.

The authors note that the risk with levofloxacin never exceeded the risk of cephalexin in any comparison!

 

 

 

Show References



Study Question: What is the association of relative hypotension (degree and duration of MPP deficit) in patients with vasopressor-dependent shock with the incidence of new significant AKI and major adverse kidney events (MAKE)? 

  • Mean Perfusion Pressure (MPP) = MAP - CVP
  • MAKE-14: composite measure of death, new initiation of RRT, or doubling of serum creatinine from the premorbid level at Day 14
  • Basal MPP estimated using pre-illness BP readings in the chart, basal CVP estimated using prior echo findings or estimated mean values

Methods:

  • Multicenter, prospective observational cohort study with 302 patients
  • Notable exclusion criteria:
    • age < 40, trauma as primary reason for ICU admission, active bleeding, unavailability of at least two preillness BP readings, pregnancy, "any condition specifically requiring a higher or a lower blood pressure target in the view of a treating clinician"

Results:

  • for every percentage increase in the time-weighted average MPP deficit, the odds of developing new significant AKI and MAKE-14 increased by 5.6% (95% CI, 2.2–9.1; P = 0.001) and 5.9% (95% CI, 2.2–9.8; P = 0.002), respectively.
  • Relationships between the risks of developing new significant AKI or MAKE-14 and the percentage of time spent with a MAP < 65 mm Hg were not statistically significant 

Take-aways:

  • Critically ill patients in shock who had higher and longer degrees of relative hypotension compared to their baseline BPs had a higher incidence of adverse kidney outcomes
  • Sidenote: also consider venous congestion/volume overload when thinking about end-organ damage (e.g. MPP not just MAP)

Show References



Title: Octreotide Shortage: Vasopressin for Variceal Bleeding

Category: Pharmacology & Therapeutics

Keywords: Octreotide, Vasopressin, Variceal Bleeding (PubMed Search)

Posted: 1/2/2021 by Wesley Oliver
Click here to contact Wesley Oliver

With a national shortage of octreotide an alternative treatment plan had to be implemented at our institution for patients presenting with variceal bleeding.

 

Drug references recommend a continuous infusion of vasopressin at 0.2 to 0.4 units/minute. Dose may be titrated as needed to a maximum dose of 0.8 units/minute with maximum duration of 24 hours to reduce incidence of adverse effects. Administer IV nitroglycerin concurrently to prevent ischemic complications and monitor closely for signs/symptoms of myocardial, peripheral, and bowel ischemia.

 

Protocol at our institution:

Vasopressin

  • Initiate vasopressin at 0.2 units/min.

  • Increase by 0.2 units/min if bleeding is not controlled after one hour (max dose: 0.8 units/min).

  • If bleeding controlled for 2 hours, can decrease by 0.2 units/min and reassess.

  • Limit use to 24 hours.

Nitroglycerin

  • Use nitroglycerin infusion to prevent adverse effects from vasopressin.

  • Initiate nitroglycerin at 40 mcg/min, titrate by 40 mcg/min to a max dose of 400 mcg/min.

  • Goal systolic blood press pressure of 90-100 mmHg.  Do not start nitroglycerin if SBP <90 mmHg.

***Please note the vasopressin dose for this indication is significantly higher than the typical dose of 0.03 units/min we use for shock.***

 

Show References



Title: TABLE: Persistently elevated serum insulin levels

Category: Toxicology

Keywords: Serum insulin level table (Attachment) (PubMed Search)

Posted: 12/31/2020 by Hong Kim, MD
Click here to contact Hong Kim, MD

 

Please see attachment for the table of serum insulin levels

Show References

Attachments



 

High dose insulin (HDI) therapy is commonly used in patients with severe beta-adrenergic antagonist and calcium channel antagonist overdose. Hypoglycemia and hypokalemia are commonly known complication of HDI therapy. However, kinetics of insulin in patients who received HDI therapy is unknown.

A 51 year-old man with amlodipine overdose was infused HDI (10 unit/kg/hr) for 37 hours; Serial serum insulin levels were drawn after discontinuation of HDI.

Serum insulin levels are shown in below table

Table    Description automatically generated

The serum insulin level remained significantly elevated during the first 24 hours (normal range: 2.6-24.9 microU/mL) and gradually decreased over 6 days.

Conclusion

  • The supraphysiologic insulin levels persist after discontinuation of HDI where patient may continue to experience hypoglycemia
  • These elevated insulin level may allow for more rapid titration or simply discontinue HDI when hemodynamic stability is achieved.

Show References

Attachments



Title: Chief complaint: "My hip snaps when I exercise"

Category: Orthopedics

Keywords: Hip pain, snapping hip, tendon (PubMed Search)

Posted: 12/27/2020 by Brian Corwell, MD (Updated: 11/25/2024)
Click here to contact Brian Corwell, MD

Chief complaint:  “My hip snaps when I exercise”

Both athletes and non-athletes may report a “snapping” sound with certain movements

This may affect up to 10% of the population

May be associated with activities than involve repetitive hip flexion

Symptoms may be due to an internal or an external cause

External causes are usually due to a tendon passing over a bony prominence

This can be felt as either an audible sensation and/or even a palpable snap

This may or may not involve pain or discomfort

This is most commonly due to a benign cause

During movements in flexion, extension or combined with internal rotation the iliotibial band may move over the greater trochanter.

Alternatively, the hamstring tendon may pass over the ischial tuberosity

There are several other causes with similar mechanisms

Symptoms are usually minimal and not serious

This can be reproduced on bedside clinical exam

               Ask the patient to identify the area of snapping with one finger which will help with anatomic localization

First line therapy is physical therapy which focuses on:

Improving muscle length if muscle is too tight   OR

Improving neuromuscular activation if problem is due to excessive muscle activation

 

 

 

 

 



Title: Can procalcitonin be used to risk stratify the febrile infant?

Category: Pediatrics

Keywords: Procalcitonin, febrile infants, sepsis (PubMed Search)

Posted: 12/18/2020 by Jenny Guyther, MD (Updated: 11/25/2024)
Click here to contact Jenny Guyther, MD

Young infants (0-90 days) have immature immune systems and are at higher risk for serious bacterial infections, particularly urinary tract infections, bacterial meningitis, and bacteremia. Infants less than 90 days old have an incidence of bacterial infections between 8 to 12.5%, while infants less than or equal to 28 days old have almost a 20% incidence.

Risk-stratification of this group has been a huge focus of research over the past couple of decades to help identify which patients require a full sepsis work-up, particularly in well-appearing infants if a source of fever is identified early. Recent studies have explored the utility of biomarkers in risk stratification in this population. A better ability to discriminate would hopefully decrease unnecessary lumbar punctures, antibiotic use, and hospital admission. Multiple studies have shown procalcitonin is able to outperform CRP for prediction of serious bacterial infections. Kuppermann et al developed a tool to identify low risk febrile infants < 60 days using procalcitonin and ANC. Their prediction rule gave a 97.7% sensitivity, 60% specificity, and 99.6% NPV for serious bacterial infection.  There have been several other studies that have looked harder to detect infections such as osteomyelitis or septic arthritis across all pediatric patients and the data has not been as promising.

Bottom line: Procalcitonin shows promise as part of a risk stratification tool in infants younger than 60 days.  Other studies have failed to show its relevance as a screening tool for osteomyelitis, septic arthritis, renal abscess or community acquired pneumonia.

Show References



Title: Postural Testing in Concussion

Category: Orthopedics

Keywords: Balance, mBESS, concussion (PubMed Search)

Posted: 12/12/2020 by Brian Corwell, MD
Click here to contact Brian Corwell, MD

The Romberg test is part of the standard neurologic examination. The patient is asked to stand with feet together, hand on hips/sides and the eyes are closed. Vestibular and proprioceptive input is being tested. 

This test is not very sensitive overall, but especially in concussed athletes.

Many concussed athletes are able to stand relatively stable despite their neurologic injury.

In order to better identify postural instability in concussion, we perform 3 separate balance tests (modified balance error scoring system, mBESS).

A) Romberg

B) Single leg stance

  1. Standing on the non dominant foot, the hip is flexed to approximately 30° and the is knee flexed to approximately 45°.
  2. NonDominant Leg: The nondominant leg is defined as the opposite leg of the preferred kicking leg

C) Tandem Stance

https://www.researchgate.net/profile/Boaz_Saffer/publication/309591285/figure/fig2/AS:669641529626644@1536666390860/Balance-Error-Scoring-System-BESS-performed-on-firm-surface-A-C_W640.jpg

 

Have patient stand quietly with hands on hips

Have patient close eyes and start 20 second trial

If error occurs tell patient to return to start as quickly as possible

Examples of errors: opening eyes, lifting hands, falling out of position

 

 

 

 



 

Antimuscarinic agents (e.g. diphenhydramine) are one of the commonly ingested substances in the US. Lorazepam is frequently used to treat delirium and agitation associated with antimuscarinic toxicity. Although physostigmine is also effective, its use is infrequent due to concerns of safety and provider’s limited experience with physostigmine.

A small blinded randomized clinical trial was conducted to compare physostigmine vs lorazepam for the treatment of antimuscarinic toxicity -delirium/agitation. 

Inclusion criteria

  • Age: 10-17 years old
  • At least one central and 2 peripheral antimuscarinic symptoms
  • Delirium and moderate agitation

 

Intervention

  1. Lorazepam 0.05 mg/kg IV bolus (max 2 mg). this dose could be repeated at 10 min if needed. then a 4 hr normal saline infusion 
  2. Physostigmine 0.02 mg/kg IV bolus (max 2 mg; over 3-5 min). this dose could be repeated at 10 min if needed. then 0.02 mg/kg/hr (max 2 mg/h) physostigmine infusion for 4 hours.

Plus administration of lorazepam (0.05 mg/kg) IV bolus (max 2 mg) every 2 hours as needed for continued agitation or delirium (at the discretion of treatment team)

 

Delirium and agitation were assessed by Confusion Assessment Method for the Intensive Care Unit score (CAM-ICU) and Richmond Agitation Sedation Score

 

Result

Study duration: March 20, 2017 to June 30, 2020

  • 175 patients presented with xenobiotic ingestion. But 19 patients were enrolled
  • Physostigmine arm: 9 (47%)
  • Lorazepam arm: 10 (53%)

Antimuscarinic agent ingested

  • Diphenhydramine: 16 (84%)
  • Dicyclomine: 1 (5%)
  • Doxylamine: 1 (5%)
  • Hyoscyamine: 1 (5%)

Proportion of subject with delirium by CAM-ICU

Prior to first bolus (p >0.99)

  • Lorazepam arm: 9/10 (90%)
  • Physostigmine arm: 9/9 (100%)

After 1st bolus (p=0.01)

  • Lorazepam: 10/10 (100%)
  • Physostigmine: 4/9 (44.4%)

End of 4 hr infusion (p <0.001)

  • Lorazepam: 10 (100%
  • Physostigmine: 2 (22.2%)

No adverse events noted in both group

 

Conclusion

  • Although this is a small study, it showed that physostigmine is better than lorazepam in treating antimuscarinic delirium and agitation.
  • This study provides additional support to the finding from a prior retrospective study (Bruns MJ et al. Ann Emerg Med. 2000;35(4):374-381), which also showed the benefits of physostigmine over benzodiazepines in the management of antimuscarinic overdose associated delirium.

Show References



Title: Does Language Preference Affect Acute Stroke Care?

Category: Neurology

Keywords: acute ischemic stroke, guideline, metric, English, non-English (PubMed Search)

Posted: 12/9/2020 by WanTsu Wendy Chang, MD (Updated: 12/10/2020)
Click here to contact WanTsu Wendy Chang, MD

  • Prior studies have shown that ethnic minorities have lower levels of stroke knowledge and lower penetrance of public health stroke education.
  • A recent study looked at whether patients’ language preference affects acute ischemic stroke care metrics.
    • 3190 stroke patients at an urban Comprehensive Stroke Center, where 300 (9.4%) had a non-English preferred language
    • They found no difference in:
      • Time from symptom discovery to ED arrival (128 min vs. 161 min for patients with English preferred language, p=0.68)
      • Arrival by EMS (65% vs. 61.3%, p=0.21)
      • Door-to-imaging time (55 min vs. 60 min, p=0.33)
      • Door-to-needle time for thrombolysis (51 min vs. 53 min, p=0.69)

Bottom Line: Patients' language preference does not appear to affect the efficiency of acute ischemic stroke care, especially at experienced high volume stroke centers. 

Show References



PEEP in the Intubated Obese Patient

  • Obesity has numerous adverse effects on the respiratory system, most notably a reduction in lung volumes.
  • The reduction in lung volumes (i.e., FRC) often result in airway closure and atelectasis.
  • The application of PEEP in the mechanically ventilated patient helps maintain alveolar patency by preventing derecruitment.
  • Importantly, the typical initial PEEP setting of 5 cm H2O is insufficient for many ventilated obese patients.
  • Pearl: In the ventilated obese patient start with an initial PEEP of 10-15 cm H2O.

Show References



Opioid Conversion Updates

Updated in 2018, some clinicians are unaware of the changes to the opioid conversion tables.

 

2010 Recommendations

 

2018 Updates

Opioid

IV (mg)

PO (mg)

 

IV (mg)

PO (mg)

Morphine

10

30

 

10

25

Fentanyl

0.1

NA

 

0.15

NA

Hydromorphone

1.5

7.5

 

2

5

Oxycodone

NA

20

 

NA

20

 

When converting between opioids, it is important to remember the following steps:

  1. Determine the patient’s level of pain and current response to therapy.
  2. Calculate current opioid requirement.
  3. Convert the opioid using table above.
  4. ASSESS! Combine Steps 1-3 to determine what is most appropriate clinically.  If the patient is suffering from severe pain, using the calculated dose may be appropriate.  If the patient is requesting a switch but is otherwise pain controlled, consider a general dose reduction of 25-50% in the new opioid.
  5. Monitor the patient for efficacy and side effects.

 

While online calculators can be helpful, opioid conversions should be done thoughtfully with a full patient assessment to determine the correct conversion for the individual patient.

 

 

Show References



Several studies have described factors associated with peri-intubation cardiac arrest in the adult population. Factors such as pre-intubation hypotension, elevated BMI, and elevated shock index (HR/SBP) have been associated with cardiac arrest following intubation in adult ED patients. Given the differences in anatomy and physiology in children, one may expect risk factors for peri-intubation cardiac arrest to differ in children.

A number of studies have examined factors associated with peri-intubation cardiac arrest in the pediatric population, but these have remained limited to the inpatient setting. These studies have found that, in hospitalized and PICU patients, the factors of hemodynamic instability, hypoxemia, history of difficult airway, pre-existing cardiac disease, and higher number of intubation attempts are associated with peri-intubation cardiac arrest. A paucity of literature exists on this airway complication in pediatric ED patients.

Pokrajac et al. provide the first study on risk factors for peri-intubation cardiac arrest in pediatric ED patients. These authors conducted a retrospective nested case-control study of pediatric patients (ages <18 years) who presented to a tertiary children’s hospital in San Diego from 2009-2017. Cases included patients who had a cardiac arrest within 20 minutes after the start of endotracheal intubation. Authors selected a number of predictors to examine, including age-adjusted hemodynamic variables, capillary refill, pulse oximetry, patient characteristics, intubation-related factors, and pre-intubation interventions.

The authors found the following:

-       Demographic characteristics:

o   Patients with peri-intubation cardiac arrest were significantly younger (<1 year of age), shorter, and more likely to have history of preexisting pulmonary disease.

-       Incident characteristics:

o   Patients with peri-intubation cardiac arrest were more likely to have:

       -Low or unobtainable SBP or DBP

       -Delayed capillary refill time

       -Low (<92%) or unobtainable pre-intubation SpO2

        -More than 1 intubation attempt than controls

        -No paralytic or sedative agent prior to intubation

o   Patients with peri-intubation cardiac arrest were NOT more likely to have increases in age-adjusted HR or pediatric shock index in comparison to controls.

o   The strongest clinical predictor for peri-intubation cardiac arrest was pre-intubation hypoxia or unobtainable SpO2. This fact is supported by children’s increased metabolic rate and thus increased oxygen consumption. This physiologic finding explains the shorter amount of time it takes children to develop acute hypoxia, particularly in the peri-intubation setting.

Bottom line: If planning to intubate a pediatric patient in the ED, keep in mind that pre-intubation systolic or diastolic hypotension, delayed capillary refill time, multiple intubation attempts, and hypoxia in particular may increase the risk for peri-intubation cardiac arrest. Consider providing apneic oxygenation to minimize hypoxemia prior to intubation.

Show References



Title: Ethanol exposures among infants in the US: 2009-2018

Category: Toxicology

Keywords: ethanol exposure, infant, national poison data system. (PubMed Search)

Posted: 12/3/2020 by Hong Kim, MD
Click here to contact Hong Kim, MD

 

Ethanol exposure among young children can result in significant morbidity. Infants and young children can be exposed to ethanol in many different ways: exploratory ingestion, mixed in formula-both intentionally and unintentionally, etc. 

A recently published study used national poison data system to characterize the ethanol exposure among infants < 12 months of age.

 

Results:

Between 2009-2018, 1,818 ethanol exposures among infants were reported. Oral ingestion was the most common (96.7%; n=1738). Annual number of ethanol exposure increased by 37.5% each year. 

Exposure site

  • Residence: 96.7% (n=1,758)
  • Public are/workplace or school: 1.6% (n=29)

Age

  • 0-2 months: 16.3% (n=296)
  • 3-5 months: 19.6% (n=357)
  • 6-8 months: 18.8% (n=341)
  • 9-11 months: 45.3% (n=824)

Clinically significant effects

  • Coma: 20
  • Hypoglycemia: 16
  • Respiratory depression: 15
  • Seizures: 13
  • Hypothermia: 9
  • Cardiac arrest: 4
  • Respiratory arrest: 3
  • Death: 5

563 infants (31%) were evaluated at hospital

38% (n=214) of the exposures were hospitalized

0-5 months of age 

  • higher odds of admission: non-critical (OR: 2.35, 95% CI: 1.41-3.92) or critical care unit (OR: 2.39; 95% CI:1.5-3.79)
  • higher odds of serious outcome (OR: 4.65; 95% IC: 3.18-6.79)

 

Conclusion

Ethanol exposure among infants is increasing each year and associated with serious clinical effects.  

Show References